Articles by K. Hariram, Pankaj Mehrotra, Rinkesh Shah, Gopal Kishore, Amaninder S. Dhillon, Ramandish Arora, Mohit Kumar Bhutani, Richa Goyal, and Mahendra Kumar Rai

One of the many ways of influencing patients to...

The digital revolution is the fourth industrial revolution. It changes models, processes and whole public sectors. In many reports you will find that, in terms of digitalization, pharma is just next to the public sector, as least digitalized. Pharma just started late. There are many reasons for that – it is one of the most regulated industries with lots of sensitive data involved and many ethical aspects. But the slowed down digitalization has a lot to do with some subjective reasons. Adopting digital technologies requires changing existing models which requires a different mindset – and this is difficult to achieve. Nowadays, in the situation of a global pandemic, we see that digital communication is not only necessary to be successful but it is a must in order to adapt to the New Normality.

Indian healthcare is sometimes an enigma: on one hand...

“If we look at major trends, people are living longer, on average, so there’s a rise in chronic diseases associated with aging. Meanwhile, healthcare workers are in short supply, and physicians and nurses do not have enough time for patients. Yet everyone has powerful computers in their pockets that give them access to technology, education, and information. Put all that together, and it’s the perfect moment for digital solutions to come to the market, change behavior, and enhance health outcomes at scale” - Bozidar Jovicevic, Global head of Digital Therapeutics, Sanofi

Executive Summary — The Paradox of Scale In the annals...

In India, where urban sleep debt is rising, obesity...

When a new cancer drug shows promise, it trends...

India’s caesarean section debate is drifting toward polarisation. On one...

In big pharma, leadership changes are rarely impulsive. They...

Executive Summary — The Paradox of Scale In the annals...

In India, where urban sleep debt is rising, obesity...

When a new cancer drug shows promise, it trends...

India’s caesarean section debate is drifting toward polarisation. On one...

In big pharma, leadership changes are rarely impulsive. They...

Executive Summary — The Paradox of Scale In the annals...

In India, where urban sleep debt is rising, obesity...

When a new cancer drug shows promise, it trends...

India’s caesarean section debate is drifting toward polarisation. On one...

In big pharma, leadership changes are rarely impulsive. They...

Executive Summary — The Paradox of Scale In the annals...

In India, where urban sleep debt is rising, obesity...

When a new cancer drug shows promise, it trends...

India’s caesarean section debate is drifting toward polarisation. On one...

In big pharma, leadership changes are rarely impulsive. They...